Introduction to Breast Carcinogenesis – Symptoms, Risks factors, Treatment and Management



Abstract Views
1438

Downloads
1001

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted May 8, 2018
Published Jul 31, 2018
10.24018/ejeng.2018.3.7.745

Abstract viewed = 1438 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

This paper aims to review current research and advancement in prevention and management of breast cancer. Occurrence of breast cancer has increased globally in the last decade. It been recorded that 15% of cancer-specific breast cancer. It is a comprehensive literature review on Breast cancer and its dependent variables created a theoretical foundation of the paper. Using the review-centric theory, a model was developed and presented to encapsulate the knowledge of the benefits associated with exercise on breast cancer outcomes through adiposity and immunological mechanisms. The model highlights breast cancer and its relationship with immunological biomarkers, obesity-related biomarkers, exercise or physical activity, biomarkers for adiposity. However more research is needed to understand the use of low doses of radiation inadequate screening, sometimes a screening test may not be able to show with certainty that there is no cancer, or occasionally may miss breast cancer. Overtreatment, some breast cancers that are found by mammography would never become a health problem in the woman’s lifetime. False negatives, other test results miss breast cancer. This shows how signs and symptoms of breast cancer, causes ad risks factors associated with breast cancer, treatment of breast cancer and the management of breast cancer malignancy can help in the decreased of mortality rate in woman and men who has and are likely to test malignancy to breast cancer disease.
Keywords: Breast Cancer Signs and symptoms Breast Pain Surgery Treatment Therapy Endocrine Therapy Nipple Retraction Lump Chemotherapy H90 inhibitors Genetic Mutation Malignancy Body mass Medication usage

Downloads

Download data is not yet available.

References

  1. Dyer, Gibb W. Jr., & Wilkins, Alan L. (1991). Better stories, not better constructs, to generate better theory: A rejoinder to Eisenhardt. Academy of Management Review, 16(3), 613-619.
     Google Scholar
  2. Eisenhardt, Kathleen M. (1989). Building Theories from case study research. Academy of Management Review, 14(4), 532-550.
     Google Scholar
  3. Gable, G.G. . (1994). Integrating Case Study and Survey Research Methods: An Example in Information Systems. European Journal of Information Systems, 3(2), 112-126.
     Google Scholar
  4. LePine, Jeffery A., & Wilcox-King, Adelaide. (2010). Developing novel theoretical insight from reviews of existing theory and research. Academy of Management Review, 35(4), 506-509.
     Google Scholar
  5. L. R. Yates et al., “Genomic Evolution of Breast Cancer Metastasis and Relapse,” Cancer Cell, vol. 32, no. 2, p. 169–184.e7, 2017.
     Google Scholar
  6. A. D. Hartkopf et al., “Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry,” Breast, vol. 37, pp. 42–51, 2018.
     Google Scholar
  7. H. Bartelink, “The changing landscape in radiotherapy for breast cancer: Lessons from long term follow-up in some European breast cancer trials,” Radiother. Oncol., vol. 121, no. 3, pp. 348–356, 2016.
     Google Scholar
  8. M. Berlière et al., “The advantages of hypnosis intervention on breast cancer surgery and adjuvant therapy,” The Breast, vol. 37, pp. 114–118, 2018.
     Google Scholar
  9. N. Arif and P. Ghezzi, “Quality of online information on breast cancer treatment options,” The Breast, vol. 37, pp. 6–12, 2018.
     Google Scholar
  10. P. Poortmans, H. Marsiglia, M. De las Heras, and M. Algara, “Clinical and technological transition in breast cancer,” Reports Pract. Oncol. Radiother., vol. 18, no. 6, pp. 345–352, 2013.
     Google Scholar
  11. J. Lester, “Local treatment of breast cancer,” Semin. Oncol. Nurs., vol. 31, no. 2, pp. 122–133, 2015.
     Google Scholar
  12. M. L. Slattery et al., “Energy homeostasis genes and breast cancer risk: The influence of ancestry, body size, and menopausal status, the breast cancer health disparities study,” Cancer Epidemiol., vol. 39, no. 6, pp. 1113–1122, 2015.
     Google Scholar
  13. P. E. Oguntunde, A. O. Adejumo, and H. I. Okagbue, “Breast cancer patients in Nigeria: Data exploration approach,” Data Br., vol. 15, pp. 47–57, 2017.
     Google Scholar
  14. K. M. de Ligt, P. E. R. Spronk, A. C. M. van Bommel, M. T. F. D. Vrancken Peeters, S. Siesling, and C. H. Smorenburg, “Patients’ experiences with decisions on timing of chemotherapy for breast cancer,” Breast, vol. 37, pp. 99–106, 2018.
     Google Scholar
  15. D. J. P. van Uden, H. W. M. van Laarhoven, A. H. Westenberg, J. H. W. de Wilt, and C. F. J. M. Blanken-Peeters, “Inflammatory breast cancer: An overview,” Crit. Rev. Oncol. Hematol., vol. 93, no. 2, pp. 116–126, 2015.
     Google Scholar
  16. J. Cortés, S. A. Im, E. Holgado, J. M. Perez-Garcia, P. Schmid, and M. Chavez-MacGregor, “The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies,” Cancer Treat. Rev., vol. 61, pp. 53–60, 2017.
     Google Scholar
  17. M. Makama et al., “An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®),” Eur. J. Cancer, vol. 75, pp. 5–13, 2017.
     Google Scholar
  18. X. Tan, F. Camacho, V. D. Marshall, J. Donohoe, R. T. Anderson, and R. Balkrishnan, “Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer,” Res. Soc. Adm. Pharm., vol. 13, no. 4, pp. 796–810, 2017.
     Google Scholar
  19. S. Lal, A. E. McCart Reed, X. M. de Luca, and P. T. Simpson, “Molecular signatures in breast cancer,” Methods, vol. 131, pp. 135–146, 2017.
     Google Scholar
  20. A. Reginelli et al., “Management of breast cancer in elderly patients,” Int. J. Surg., vol. 12, no. S2, pp. S187–S192, 2014.
     Google Scholar
  21. G. Rondanina, M. Puntoni, A. Guerrieri-Gonzaga, D. Marra, B. Bonanni, and A. DeCensi, “Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone users,” Breast, vol. 34, pp. 108–114, 2017.
     Google Scholar
  22. A. Falanga, L. Russo, V. Milesi, and A. Vignoli, “Mechanisms and risk factors of thrombosis in cancer,” Crit. Rev. Oncol. Hematol., vol. 118, no. June, pp. 79–83, 2017.
     Google Scholar
  23. S. H. Ewaid and L. H. A. Al-Azzawi, “Breast cancer risk assessment by Gail Model in women of Baghdad,” Alexandria J. Med., vol. 53, no. 2, pp. 0–3, 2016.
     Google Scholar
  24. J. Baselga, R. E. Coleman, J. Cortés, and W. Janni, “Advances in the management of HER2-positive early breast cancer,” Crit. Rev. Oncol. Hematol., vol. 119, no. July, pp. 113–122, 2017.
     Google Scholar
  25. Z. Ghodsi, A. Salehi, and S. Hojjatoleslami, “Knowledge of Iranian Women about Warning Signs and Risk Factors for Breast Cancer,” Procedia - Soc. Behav. Sci., vol. 93, pp. 343–348, 2013.
     Google Scholar
  26. M. C. Lauridsen, K. R. Tørsleff, H. Husted, and C. Erichsen, “Physiotherapy treatment of late symptoms following surgical treatment of breast cancer,” The Breast, vol. 9, no. 1, pp. 45–51, 2000.
     Google Scholar
  27. C. Coleman, “Early Detection and Screening for Breast Cancer,” Semin. Oncol. Nurs., vol. 33, no. 2, pp. 141–155, 2017.
     Google Scholar
  28. W. E. Barlow et al., “Performance of diagnostic mammography for women with signs or symptoms of breast cancer.,” J. Natl. Cancer Inst., vol. 94, no. 15, pp. 1151–9, 2002.
     Google Scholar
  29. S. Keeney, H. McKenna, P. Fleming, and S. McIlfatrick, “An exploration of public knowledge of warning signs for cancer,” Eur. J. Oncol. Nurs., vol. 15, no. 1, pp. 31–37, 2011.
     Google Scholar
  30. A. Mangla, N. Agarwal, F. Saei Hamedani, J. Liu, S. Gupta, and M. R. Mullane, “Metastasis of cervical cancer to breast: A case report and review of literature,” Gynecol. Oncol. Reports, vol. 21, no. June, pp. 48–52, 2017.
     Google Scholar
  31. C. E. Champ et al., “Assessing Changes in the Activity Levels of Breast Cancer Patients During Radiation Therapy,” Clin. Breast Cancer, pp. 1–6, 2017.
     Google Scholar
  32. V. Lope et al., “Physical activity and breast cancer risk by pathological subtype,” Gynecol. Oncol., vol. 144, no. 3, pp. 577–585, 2017.
     Google Scholar
  33. A. Sonnenblick, N. Pondé, and M. Piccart, “Metastatic breast cancer: The Odyssey of personalization,” Mol. Oncol., vol. 10, no. 8, pp. 1147–1159, 2016.
     Google Scholar
  34. C. Bohon, “Cancer Recognition and Screening for Common Breast Disorders and Malignancy,” Obstet. Gynecol. Clin. North Am., vol. 44, no. 2, pp. 257–270, 2017.
     Google Scholar
  35. K. J. Ruddy et al., “Quality of life and symptoms in male breast cancer survivors,” The Breast, vol. 22, no. 2, pp. 197–199, 2013.
     Google Scholar
  36. S. L. Savaridas, D. B. Taylor, D. Gunawardana, and M. Phillips, “Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors,” Clin. Radiol., pp. 1–9, 2017.
     Google Scholar
  37. A. C. P. Ribeiro Pereira, R. J. Koifman, and A. Bergmann, “Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up,” The Breast, vol. 36, pp. 67–73, 2017.
     Google Scholar
  38. F. E. Lundberg, A. N. Iliadou, K. Rodriguez-Wallberg, C. Bergh, K. Gemzell-Danielsson, and A. L. V. Johansson, “Ovarian stimulation and risk of breast cancer in Swedish women,” Fertil. Steril., vol. 108, no. 1, pp. 137–144, 2017.
     Google Scholar
  39. R. Glaser and C. Dimitrakakis, “Testosterone and breast cancer prevention,” Maturitas, vol. 82, no. 3, pp. 291–295, 2015.
     Google Scholar
  40. M. Lambertini et al., “Fertility and pregnancy issues in BRCA-mutated breast cancer patients,” Cancer Treat. Rev., vol. 59, pp. 61–70, 2017.
     Google Scholar
  41. C. a Gabriel and S. M. Domchek, “Breast cancer in young women.,” Breast Cancer Res., vol. 12, no. 5, p. 212, 2010.
     Google Scholar
  42. C. Rousset-Jablonski and A. Gompel, “Screening for familial cancer risk: Focus on breast cancer,” Maturitas, no. August, pp. 0–1, 2017.
     Google Scholar
  43. M. L. Peters, J. E. Garber, and N. Tung, “Managing hereditary breast cancer risk in women with and without ovarian cancer,” Gynecol. Oncol., vol. 146, no. 1, pp. 205–214, 2017.
     Google Scholar
  44. S. Shmuel, A. J. White, and D. P. Sandler, “Residential exposure to vehicular traffic-related air pollution during childhood and breast cancer risk,” Environ. Res., vol. 159, no. June, pp. 257–263, 2017.
     Google Scholar
  45. F. R. James, S. Wootton, A. Jackson, M. Wiseman, E. R. Copson, and R. I. Cutress, “Obesity in breast cancer - What is the risk factor?,” Eur. J. Cancer, vol. 51, no. 6, pp. 705–720, 2015.
     Google Scholar
  46. D. Maliou and A. Bitam, “Implication of milk and dairy products consumption through insulin-like growth factor-I in induction of breast cancer risk factors in women,” Nutr. Clin. Metab., vol. 29, no. 4, pp. 219–225, 2015.
     Google Scholar
  47. N. Y. Sofi et al., “Title: Reproductive factors, nutritional status and serum 25(OH)D levels in women with breast cancer: A case control study Reproductive factors, nutritional status and serum 25(OH)D levels in women with breast cancer: A case control study,” J. Steroid Biochem. Mol. Biol., vol. 25, 2017.
     Google Scholar
  48. Z. Kleibl and V. N. Kristensen, “Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management,” The Breast, vol. 28, pp. 136–144, 2016.
     Google Scholar
  49. F. MacNeill and A. Karakatsanis, “Over surgery in breast cancer,” The Breast, vol. 31, pp. 284–289, 2017.
     Google Scholar
  50. C.-Y. Liu, C.-Y. Wu, K. Petrossian, T.-T. Huang, L.-M. Tseng, and S. Chen, “Treatment for the endocrine resistant breast cancer: Current options and future perspectives,” J. Steroid Biochem. Mol. Biol., vol. 172, no. July, pp. 166–175, 2017.
     Google Scholar
  51. E. Folkerd and M. Dowsett, “Sex hormones and breast cancer risk and prognosis,” The Breast, vol. 22, pp. S38–S43, 2013.
     Google Scholar
  52. A. Lee and M. Djamgoz, “Triple negative breast cancer: emerging therapeutic modalities and novel combination therapies,” Manuscr. under Editor. Rev., 2017.
     Google Scholar
  53. R. K. Charaghvandi, S. Yoo, B. van Asselen, A. Rodrigues, D. H. J. G. van den Bongard, and J. K. Horton, “Treatment constraints for single dose external beam preoperative partial breast irradiation in early-stage breast cancer,” Clin. Transl. Radiat. Oncol., vol. 6, pp. 7–14, 2017.
     Google Scholar
  54. X. Zhou et al., “β-Glucosidase inhibition sensitizes breast cancer to chemotherapy,” Biomed. Pharmacother., vol. 91, pp. 504–509, 2017.
     Google Scholar
  55. C. Y. Kuo, S. Y. Liang, S. L. Tsay, T. J. Wang, and S. F. Cheng, “Symptom management tasks and behaviors related to chemotherapy in Taiwanese outpatients with breast cancer,” Eur. J. Oncol. Nurs., vol. 19, no. 6, pp. 654–659, 2015.
     Google Scholar
  56. C. Wang et al., “Triple negative breast cancer in Asia: An insider’s view,” Cancer Treat. Rev., vol. 62, pp. 29–38, 2018.
     Google Scholar
  57. M. E. Cazzaniga, M. R. Dionisio, and F. Riva, “Metronomic chemotherapy for advanced breast cancer patients,” Cancer Lett., vol. 400, pp. 252–258, 2017.
     Google Scholar
  58. M. Sibbering and C.-A. Courtney, “Management of breast cancer: basic principles,” Surg., vol. 34, no. 1, pp. 25–31, 2016.
     Google Scholar
  59. S. A. Massarweh and G. L. Choi, “Special considerations in the evaluation and management of breast cancer in men,” Curr. Probl. Cancer, vol. 40, no. 2–4, pp. 163–171, 2016.
     Google Scholar
  60. S. M. Rosenberg and A. H. Partridge, “Management of breast cancer in very young women,” Breast, vol. 24, pp. S154–S158, 2015.
     Google Scholar
  61. A. De, G. Kuppusamy, and V. V. S. R. Karri, “Affibody molecules for molecular imaging and targeted drug delivery in the management of breast cancer,” Int. J. Biol. Macromol., 2017.
     Google Scholar
  62. J. Cvetkovi?? and M. Nenadovi??, “Depression in breast cancer patients,” Psychiatry Res., vol. 240, pp. 343–347, 2016.
     Google Scholar
  63. I. E. Smith and C. Fribbens, “Management of breast cancer in older and frail patients,” Breast, vol. 24, pp. S159–S162, 2015.
     Google Scholar
  64. A. Nicolini, P. Ferrari, and M. J. Duffy, “Prognostic and predictive biomarkers in breast cancer: Past, present and future,” Semin. Cancer Biol., no. August, 2017.
     Google Scholar
  65. T. Shen, C. Gao, K. Zhang, G. P. Siegal, and S. Wei, “Prognostic Outcomes in Advanced Breast Cancer: The Metastasis-free Interval is Important.,” Hum. Pathol., 2017.
     Google Scholar
  66. A. Patil and G. V. Sherbet, “Therapeutic approach to the management of HER2-positive breast cancer metastatic to the brain,” Cancer Lett., vol. 358, no. 2, pp. 93–99, 2015.
     Google Scholar
  67. Y. Wang, J. Zhou, Z. Wang, P. Wang, and S. Li, “Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion,” Biochem. Biophys. Res. Commun., vol. 493, no. 1, pp. 429–436, 2017.
     Google Scholar
  68. C. Tsai, W. Su, J. Liang, H. Hsu, and W. Chen, “Original Article Glypican-3 Expression in Breast Cancer 原著論文 乳癌的 Glypican-3 之表現 Specimen Selection and Data Collection,” J. Cancer Res. Pract., vol. 2, no. 4, pp. 285–292, 2015.
     Google Scholar
  69. F. H. Hsiao et al., “A longitudinal study of diurnal cortisol patterns and associated factors in breast cancer patients from the transition stage of the end of active cancer treatment to post-treatment survivorship,” Breast, vol. 36, pp. 96–101, 2017.
     Google Scholar
  70. M. N. Liao et al., “Change and predictors of symptom distress in breast cancer patients following the first 4 months after diagnosis,” J. Formos. Med. Assoc., vol. 114, no. 3, pp. 246–253, 2015.
     Google Scholar
  71. S. Doyle, J. Steel, and G. Porter, “Imaging male breast cancer,” Clin. Radiol., vol. 66, no. 11, pp. 1079–1085, 2011.
     Google Scholar
  72. C. Rousset-Jablonski and A. Gompel, “Screening for familial cancer risk: Focus on breast cancer,” Maturitas, vol. 105, no. July, pp. 69–77, 2017.
     Google Scholar
  73. W. Haven, “The Transition Experience to Breast Cancer Survivorship,” Semin. Oncol. Nurs., vol. 31, no. 2, pp. 178–182, 2015.
     Google Scholar
  74. F. A. Peccatori, G. Codacci-Pisanelli, M. Del Grande, G. Scarfone, F. Zugni, and G. Petralia, “Whole body MRI for systemic staging of breast cancer in pregnant women,” Breast, vol. 35, pp. 177–181, 2017.
     Google Scholar
  75. A. B. Chagpar, “On baseball and breast cancer,” Am. J. Surg., pp. 10–13, 2017.
     Google Scholar
  76. A. H. Christian, D. O’Malley, A. Barac, S. M. Miller, and S. V. Hudson, “Cardiovascular risk and communication among early stage breast cancer survivors,” Patient Educ. Couns., vol. 100, no. 7, pp. 1360–1366, 2017.
     Google Scholar
  77. S.-Q. Qiu et al., “Evolution in sentinel lymph node biopsy in breast cancer,” Crit. Rev. Oncol. Hematol., 2017.
     Google Scholar
  78. T. Kim et al., “p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2,” J. Exp. Med., vol. 208, no. 5, pp. 875–883, 2011.
     Google Scholar
  79. P. Dong et al., “Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis,” Oncogene, vol. 32, no. 27, pp. 3286–3295, 2013.
     Google Scholar
  80. D. W. Cramer, A. F. Vitonis, K. L. Terry, W. R. Welch, and L. J. Titus, “The Association Between Talc Use and Ovarian Cancer,” Epidemiology, vol. 27, no. 3, pp. 334–346, 2016.
     Google Scholar
  81. Barnard, M. E., Boeke, C. E., & Tamimi, R. M. (2015). Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochimica et Biophysica Acta - Reviews on Cancer, 1856(1), 73–85.
     Google Scholar
  82. Davies, E. L. (2016). Breast cancer. Medicine, 44(1), 42–46.
     Google Scholar
  83. Harbeck, N., & Gnant, M. (2017). Breast cancer. The Lancet, 389(10074), 1134–1150.
     Google Scholar
  84. Jansen, L. A., Backstein, R. M., & Brown, M. H. (2014). Breast size and breast cancer: A systematic review. Journal of Plastic, Reconstructive & Aesthetic Surgery, 67(12), 1615–1623.
     Google Scholar
  85. Kabel, A. M. (2017). Tumor markers of breast cancer: New prospectives. Journal of Oncological Sciences, 3(1), 5–11.
     Google Scholar
  86. Klevos, G. A., Ezuddin, N. S., Vinyard, A., Ghaddar, T., Gort, T., Almuna, A., … Welsh, C. F. (2017). A Breast Cancer Review: Through the Eyes of the Doctor, Nurse, and Patient. Journal of Radiology Nursing, 36(3), 158–165.
     Google Scholar
  87. Lope, V., Martín, M., Castelló, A., Casla, S., Ruiz, A., Baena-Cañada, J. M., … Pollán, M. (2017). Physical activity and breast cancer risk by pathological subtype. Gynecologic Oncology, 144(3), 577–585.
     Google Scholar
  88. Mahvish Muzaffar, S. K. (2016). Impact of Primary Tumor Surgery in Stage IV Male Breast Cancer. Clinic Breast Cancer, 17(3), 1–7.
     Google Scholar
  89. McNamara, K. M., Kannai, A., & Sasano, H. (2017). Possible roles for glucocorticoid signalling in breast cancer. Molecular and Cellular Endocrinology, 1–13.
     Google Scholar
  90. Moira, L., Orsi, F., & Adam, A. (2017). Interventional radiology in breast cancer. The Breast, 35, 98–103.
     Google Scholar
  91. Rodin, D., Knaul, F. M., Lui, T. Y., & Gospodarowicz, M. (2016). Radiotherapy for breast cancer: The predictable consequences of an unmet need. Breast, 29, 120–122.
     Google Scholar
  92. Simapivapan, P., Boltong, A., & Hodge, A. (2016). To what extent is alcohol consumption associated with breast cancer recurrence and second primary breast cancer?: A systematic review. Cancer Treatment Reviews, 50, 155–167.
     Google Scholar
  93. Tang, Y., Wang, Y., Kiani, M. F., & Wang, B. (2016). Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer. Clinical Breast Cancer, 16(5), 335–343.
     Google Scholar
  94. Xiao, Q., Signorello, L. B., Brinton, L. A., Cohen, S. S., Blot, W. J., & Matthews, C. E. (2016). Sleep duration and breast cancer risk among black and white women. Sleep Medicine, 20, 25–29.
     Google Scholar
  95. Pudkasam, S., Tangalakis, K., Chinlumprasert, N., Apostolopoulos, V., & Stojanovska, L. (2017). Breast cancer and exercise: The role of adiposity and immune markers. Maturitas, (April), 0–1.
     Google Scholar


Most read articles by the same author(s)